Smith & Nephew (LON:SN) Insider Acquires £101,668 in Stock

Smith & Nephew plc (LON:SN) insider David King purchased 2,800 shares of the company’s stock in a transaction on Monday, August 18th. The stock was purchased at an average price of GBX 3,631 per share, for a total transaction of £101,668.

Smith & Nephew Trading Down 0.1%

SN opened at GBX 1,383 on Friday. The company’s fifty day simple moving average is GBX 1,180.15 and its 200 day simple moving average is GBX 1,102.83. The company has a debt-to-equity ratio of 70.22, a quick ratio of 0.84 and a current ratio of 2.51. The company has a market capitalization of £15.16 billion, a PE ratio of 49.79, a PEG ratio of 0.46 and a beta of 0.62.

Wall Street Analyst Weigh In

A number of analysts recently weighed in on the stock. JPMorgan Chase & Co. raised their target price on shares of Smith & Nephew from GBX 1,357 to GBX 1,438 and gave the stock an “overweight” rating in a report on Wednesday, August 6th. Berenberg Bank lifted their price objective on shares of Smith & Nephew from GBX 1,100 to GBX 1,300 and gave the stock a “hold” rating in a research report on Thursday, August 7th. Finally, Deutsche Bank Aktiengesellschaft lifted their target price on shares of Smith & Nephew from GBX 1,300 to GBX 1,400 and gave the company a “hold” rating in a research note on Wednesday, August 6th. One analyst has rated the stock with a Buy rating and two have given a Hold rating to the stock. According to data from MarketBeat.com, Smith & Nephew presently has a consensus rating of “Hold” and an average price target of GBX 1,379.33.

Smith & Nephew Company Profile

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products.